Key statistics
As of last trade, Carisma Therapeutics Inc (W2J:BER) traded at 0.9415, 28.71% above the 52 week low of 0.7315 set on Aug 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.9455 |
---|---|
High | 0.9455 |
Low | 0.9055 |
Bid | 0.8705 |
Offer | 1.02 |
Previous close | 0.933 |
Average volume | 0.00 |
---|---|
Shares outstanding | 41.54m |
Free float | 28.79m |
P/E (TTM) | -- |
Market cap | 41.96m USD |
EPS (TTM) | -1.78 USD |
Data delayed at least 15 minutes, as of Nov 11 2024 15:58 GMT.
More ▼
Press releases
- Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma
- Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
- Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024
- Carisma Therapeutics Announces Changes to its Board of Directors
- Carisma Therapeutics Announces Upcoming Presentations at SITC 2024
- Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases
- Carisma Therapeutics to Present at Upcoming Conferences
More ▼